 |
 |

Isolated Microtia as a Marker for Unsuspected Hemifacial Microsomia
Ivan J. Keogh, MD, FRCS;
Maria J. Troulis, DDS, MSc;
Angelo A. Monroy, MD;
Roland D. Eavey, MD, SM;
L. B. Kaban, MD, DMD
Arch Otolaryngol Head Neck Surg. 2007;133(10):997-1001.
Objective To determine the proportion of hemifacial microsomia (HFM) in patients with unilateral or bilateral "isolated" microtia.
Design Prospective cohort clinical study.
Setting University-affiliated, tertiary referral clinic for patients with microtia.
Patients One hundred consecutive patients with isolated microtia.
Interventions All the patients underwent a clinical examination and audiologic evaluation. The OMENS classification system was used to grade the severity of craniofacial features: orbital deformity, mandibular hypoplasia, ear deformity, nerve (cranial nerve VII) involvement, and soft-tissue deficiency. Each anatomical abnormality was graded from 0 (normal) to 3 (most severe) (score range, 0-15).
Main Outcome Measures The OMENS scores, percentage of patients with isolated microtia and undiagnosed HFM, and isolated microtia as an early clinical marker for HFM.
Results Forty patients (40%) with microtia were determined to have HFM (31 unilateral and 9 bilateral). Mean patient age was 9.2 years (range, 6 weeks to 41 years), with male predominance (27 males and 13 females). The OMENS scores were less than 5 in 24 patients and 6 to 10 in 16 patients. Thirty patients had cranial nerve deficits, and 37 had mandibular asymmetry. Thirty-seven patients demonstrated conductive hearing loss, and 1 had sensorineural hearing loss.
Conclusions Isolated microtia served as an early clinical marker for asymmetrical facial growth in 40% of the patients. Isolated microtia and HFM could represent a spectrum of expression of the same developmental phenomenon.
Author Affiliations: Department of Otolaryngology, Pediatric Otolaryngology Service, and Department of Otology and Laryngology, Massachusetts Eye and Ear Infirmary (Drs Keogh, Monroy, and Eavey); Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital (Drs Troulis and Kaban); and Department of Genetics, Harvard Medical School (Drs Keogh, Monroy, and Eavey), Boston, Massachusetts; and Royal College of Surgeons in Ireland, Dublin (Dr Keogh). Dr Keogh is currently at the Academic Department of Otolaryngology, University College Hospital, Galway, Ireland.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|